investor1990 previously owned

Description:

Okay, so I owned all the following stocks back when I thought DNDN was a breakthrough stock that was going to go to 30-40 once the FDA approved it on May 15th. Instead, on May 9th, the FDA issued a complete response letter to Dendreon asking for more information before they could consider approval of Provenge, the company's only drug therapy for late-stage prostate cancer. This took the wind out of the sails of the stock and dropped it down by 60%. I lost more than that percentage of my capital, and sold everything below, mainly at a loss. So if these companies end up going up in the future, I'll be a little upset. However, I learned a valuable lesson about liquidity and time. You can never have enough of either.

Most Viewed Portfolios

View All

Articles

5 Stocks Poised for Breakouts

05.25.12 | 11:47 AM

 WINDERMERE, Fla. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high, ...

8 Stocks Soaring on Big Volume

05.25.12 | 01:13 PM

WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don’t just look at a stock’s price moves; they also ...

More Articles
blog comments powered by Disqus
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter